Literature DB >> 32434806

Management of acute kidney injury in COVID-19.

Mohamed Hassanein1, George Thomas1, Jonathan Taliercio1.   

Abstract

Acute kidney injury has been reported in as many as 29% of COVID-19 patients. Reported risk factors include elevated baseline serum creatinine, elevated blood urea nitrogen, acute kidney injury, proteinuria, and hematuria. Suspected causes include sepsis and acute tubular necrosis resulting from renal hypoperfusion, cytokine release syndrome, direct viral invasion, renal medullary hypoxia secondary to alveolar damage, rhabdomyolysis, and cardiorenal syndrome due to viral myocarditis.
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Year:  2020        PMID: 32434806     DOI: 10.3949/ccjm.87a.ccc034

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  4 in total

1.  Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients.

Authors:  Jian Qu; Hai-Hong Zhu; Xue-Jian Huang; Ge-Fei He; Ji-Yang Liu; Juan-Juan Huang; Ying Chen; Qiang Qu; Ya-Li Wu; Xiang-Yu Chen; Qiong Lu
Journal:  Infect Drug Resist       Date:  2021-08-10       Impact factor: 4.003

2.  Racial differences in cardiopulmonary outcomes of hospitalized COVID-19 patients with acute kidney injury.

Authors:  Obiora Egbuche; Temidayo Abe; Shirley I Nwokike; Opeyemi Jegede; Kenechukwu Mezue; Titilope Olanipekun; Ifeoma Onuorah; Melvin R Echols
Journal:  Rev Cardiovasc Med       Date:  2021-12-22       Impact factor: 4.430

3.  Comparing the Value of Cystatin C and Serum Creatinine for Evaluating the Renal Function and Predicting the Prognosis of COVID-19 Patients.

Authors:  Sichao Chen; Jinpeng Li; Zeming Liu; Danyang Chen; Ling Zhou; Di Hu; Man Li; Wei Long; Yihui Huang; Jianglong Huang; Shipei Wang; Qianqian Li; Wen Zeng; Liang Guo; Xiaohui Wu
Journal:  Front Pharmacol       Date:  2021-03-22       Impact factor: 5.810

4.  Cytokine release syndrome complicated with rhabdomyolysis after chimeric antigen receptor T-cell therapy: A case report.

Authors:  Lan Zhang; Wei Chen; Xiao-Min Wang; Shu-Qing Zhang
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.